Autoantibodies to Gaba-Ergic Neurons & Pancreatic Beta Cells in Stiff-Man Syndrome
NEJM 322:1555-1560, Solimena,M.,et al, 1990
Intrathecal Baclofen for Severe Spinal Spasticity
NEJM 320:1517-1521, 1553-15551989., Penn,R.D.,et al, 1989
Intrathecal Baclofen for Long-Term Treatment of Spasticity:A Multi-Centre Study
JNNP 52:933-939, Ochs,G.,et al, 1989
Vigabatrin
Editorial, Lancet 1:532-5331989., , 1989
Baclofen for Intractable Hiccups
NEJM 319:1354, Burke,A.M.,et al, 1988
Periodic Sharp Waves in Baclofen-Induced Encephalopathy
Arch Neurol 45:814-815, Hormes,J.T.,et al, 1988
Autoantibodies to Glutamic Acid Decarboxylase in Pt with Stiff-Man Syndr, Epilepsy & Type I Diabetes Mellitus
NEJM 318:1012-1020, Solimena,M.,et al, 1988
Stiff-Man Syndrome, An Autoimmune Disease
NEJM 318:1060-1062, Layzer,R.B., 1988
Vigabatrin for Refractory Complex Partial Seizures:Multicenter Single-Blind Study with Long-Term Follow-Up
Neurol 37:184-189, Browne,T.R.,et al, 1987
Glossopharyngeal Neuralgia:Successful Treatment with Baclofen
Ann Neurol 21:514-515, Ringel,R.A.&Roy,E.P., 1987
Aggravated CNS Depression with Urinary Retention Secondary to Baclofen Administration
Arch Int Med 145:1717-1718, White,W.B., 1985
Encephalopathy Associated with Baclofen
Ann Neurol 17:617-618, Abarbanel,J.,et al, 1985
Olivopontocerebellar Atrophy with Dementia, Blindness, & Chorea, Response to Baclofen
Arch Neurol 42:757-758, Trauner,D.A., 1985
Continuous Intrathecal Baclofen for Severe Spasticity
Lancet 2:125-127, Penn,R.D.&Kroin,J.S., 1985
Drug-Induced Seizures:A 10-Year Experience
Neurol 34:1582-1586, Messing,R.O.,et al, 1984
Baclofen in the Treatment of Trigeminal Neuralgia:Double-Blind Study & Long-Term Follow-up
Ann Neurol 15:240-244, Fromm,G.H.,et al, 1984
Morbilliform Rash Secondary to Baclofen Ingestion
Ann Neurol 13:216, Lynde,C.W.,et al, 1983
Baclofen, Its Effect on Seizure Frequency
Arch Neurol 40:28-29, Terrence,C.F.,et al, 1983
Efficacy of a Combination of Sodium Valproate & Baclofen in Meige's Disease (idiopathic orofacial dystonia)
BMJ 285:853, Brennan,M.J.W.,et al, 1982
Baclofen in the Treatment of Stiff-Man Syndrome
Ann Neurol 9:511-512, Miller,F.,et al, 1981
Spasticity
et al (Part 1 & 2) NEJM 304:28-33, 96-99., Young,R.R., 1981
Complications of Baclofen Withdrawal
Arch Neurol 38:588-589, Terrence,C.F.,et al, 1981
Treatment of Periodic Alternating Nystagmus
Ann Neurol 8:609-611, Halmagyi,G.M.,et al, 1980
Dystonic Foot Response of Parkinsonism
Arch Neurol 37:132-136, Nausieda,P.A.,et al, 1980
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980
Levels of y-Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders
Arch Neurol 37:352-355, Manyam,N.V.B.,et al, 1980
Baclofen in Treatment of the"Stiff-Man Syndrome
Arch Neurol 37:600-601, Whelan,J.L., 1980
Baclofen in Trigeminal Neuralgia
Arch Neurol 37:768-771, Fromm,G.H.,et al, 1980
Tardive Dyskinesia
Editorial, BMJ 2:13131979., , 1979
Isoniazid Therapy of Huntington Disease
Neurol 29:370-375, Perry,T.L.,et al, 1979
Huntington's Disease, CSF GABA Level in at-risk Individuals
Arch Neurol 35:728-730, Manyam,N.V.B.,et al, 1978
Huntington's Disease:Treatment with Muscimol, a GABA-Mimetic Drug
Ann Neurol 4:279-284, Shoulson,I.,et al, 1978
Baclofen for Spasticity in Multiple Sclerosis
Neurol 28:1094-1098, Feldman,R.G.,et al, 1978
Vitamin B-6-Dependent Seizures:Pathology & Chemical Findings in Brain
Neurol 28:47, Lott,I.T.,et al, 1978
Valproic Acid in Epilepsy:Clinical & Pharmacological Effects
Ann Neurol 3:20, Mattson,R.H.,et al, 1978
Baclofen, A New Antispastic Drug
Arch Neurol 34:422, Sachais,B.A.,et al, 1977
Treatment of Huntington's Chorea with Isoniazid
NEJM 297:840, 1977. (Letter), Perry,T.L.,et al, 1977
Identification of GABA in Human CSF by Gas Liquid Chromatography & Mass Spectrometry
NEJM 296:692, Huizinga,J.D.,et al, 1977
Huntington's Chorea, Changes in Neurotransmitter Receptors in the Brain
NEJM 294:1305, Enna,S.J.,et al, 1976
Overdose of Lioresal
Neurol 26:1105, Paulson,G.W., 1976
Huntington's Chorea-Deficiency of Y-Aminobutynic Acid in Brain
NEJM 288:337, 1973, 289:104, 1973, 292:10295., Perry,T.,et al, 1975
Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975
The Chemistry & Kinetics of Lioresal
Postgrad Med Oct Suppl 1972, p 9., Faigle,J.,et al, 1972
Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation
NEJM 392:1749-1751, Gorey,S., 2025
Aspirin Continuation or Discontinuation in Surgically Treated Chronic Subdural Hematoma, A Randomized Clinical Trial
JAMA Neurol 82:551-559, Kamenova,M.,et al, 2025
Efficacy and Safety of Ofatumumab Treatment for Anti-NMDA Receptor Autoimmune Encephalitis (OFF-AE): A Prospective, Multicenter Cohort Study
Ann Neurol 98:80-92, Guo,K.,et al, 2025
Rapid Diagnosis of Intracerebral Hemorrhage in Patients with Acute Stroke by Measuring Prehospital GFAP Levels on a Point-of-Care Device (DETECT)
Neurol 105: e213823, Kalra,L-P.,et al, 2025
AAV9-Mediated Gene Therapy for Infantile-Onset Pompes Disease
NEJM 392:2438-2446, 2477, Ma,X.,et al, 2025
Outcomes of Patients with Embolic Stroke of Undetermined Source Treated with Antiplatelet Agents or Anticoagulation, A Multicenter Cohort Study
Neurol 105: e213876, Seigler,J.E.,et al, 2025
Clinicopathologic conference, Malignant Mixed Germ-Cell Tumor and Anti-NMDA Receptor Encephalitis
NEJM 303:488-496, Case 22-2025, 2025